High body mass index in adolescent girls precedes psoriasis hospitalization

Acta Dermato-Venereologica

Volumn 90, Issue 5, 2010, Pages 488-493

  Bryld, Lars Erik ^a   Sørensen, Thorkild I A ^b   Andersen, Klaus Kaae ^c   Jemec, Gregor B E ^a   Baker, Jennifer L ^b  

^a ROSKILDE HOSPITAL   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Epidemiology; Historical cohort; Linkage record; Psoriasis BMI

Indexed keywords

ADOLESCENT; ADULTHOOD; ANTHROPOMETRY; ARTICLE; BIRTH; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHILDHOOD; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; SCHOOL CHILD; SCHOOL HEALTH SERVICE;

ADOLESCENT; AGE FACTORS; BODY MASS INDEX; CHILD; DENMARK; FEMALE; HOSPITALIZATION; HUMANS; LIKELIHOOD FUNCTIONS; LINEAR MODELS; LOGISTIC MODELS; MALE; OBESITY; PSORIASIS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 77957673578     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0931     Document Type: Article

References (58)

1. McGowan JW, Pearce DJ, Chen J, Richmond D, Balkrishnan R, Feldman SR. The skinny on psoriasis and obesity. Arch Dermatol 2005; 141: 1601-1602.
2. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
3. Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-67. (Pubitemid 40981424)
4. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835. (Pubitemid 44556851)
5. Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 2002; 47: 821-833.
6. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000; 356: 385-390.
7. Mauras N, Delgiorno C, Kollman C, Bird K, Morgan M, Sweeten S, et al. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab [Internet] 2010 Jan 8 [cited 2010 Mar 3]. Available from: URL: http://www.ncbi.nlm.nih.gov/pubmed/20061420.
8. Bartfai T, Waalen J, Buxbaum JN. Adipose tissue as a modulator of clinical inflammation: does obesity reduce the prevalence of rheumatoid arthritis? J Rheumatol 2007; 34: 488-492.
9. Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-1534.
10. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 2007; 167: 1670-1675.
11. Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007; 157: 649-655.
12. Sørensen TI, Sonne-Holm S. Risk in childhood of development of severe adult obesity: retrospective, population-based case-cohort study. Am J Epidemiol 1988; 127: 104-113. (Pubitemid 18034371)
13. Baker JL, Olsen LW, Andersen I, Pearson S, Hansen B, Sørensen TIA. Cohort Profile: the Copenhagen School Health Records Register. Int J Epidemiol 2009; 38: 656-662.
14. Baker JL, Olsen LW, Sørensen TIA. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357: 2329-2337. (Pubitemid 350223387)
15. The R Development Core Team. R: a language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2005. Available from: URL: http://www.r-project.org/.
16. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73. (Pubitemid 46934281)
17. Hamminga EA, van der Lely AJ, Neumann HAM, Thio HB. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006; 67: 768-773. (Pubitemid 44062144)
18. Murray ML, Bergstresser PR, Adams-Huet B, Cohen JB. Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity. Clin Exp Dermatol 2009; 34: 140-144.
19. Aksglaede L, Olsen LW, Sørensen TIA, Juul A. Forty years trends in timing of pubertal growth spurt in 157,000 Danish school children. PLoS ONE 2008; 3: e2728.
20. Seyhan M, Coşkun BK, Saǧlam H, Ozcan H, Karincaoǧlu Y. Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatr Int 2006; 48: 525-530.
21. al-Fouzan AS, Nanda A. A survey of childhood psoriasis in Kuwait. Pediatr Dermatol 1994; 11: 116-119.
22. Holm EA, Esmann S, Jemec GBE. Does visible atopic dermatitis affect quality of life more in women than in men? Gend Med 2004; 1: 125-130.
23. Jemec GB, Wojnarowska F. The distribution of p29 protein in normal human skin. Br J Dermatol 1987; 117: 217-224.
24. Pelletier G, Ren L. Localization of sex steroid receptors in human skin. Histol Histopathol 2004; 19: 629-636.
25. Schmuth M, Watson RE, Deplewski D, Dubrac S, Zouboulis CC, Griffiths CE. Nuclear hormone receptors in human skin. Horm Metab Res 2007; 39: 96-105. (Pubitemid 46535567)
26. Krahn-Bertil E, Bolzinger M, Andre V, Orly I, Kanitakis J, Rousselle P, et al. Expression of estrogen-related receptor gamma (ERRgamma) in human skin. Eur J Dermatol 18: 427-432.
27. Bertil E, Bolzinger M, André V, Rousselle P, Damour O. Expression of oestrogen-related receptor alpha in human epidermis. Exp Dermatol 2008; 17: 208-213. (Pubitemid 351233866)
28. Im S, Lee ES, Kim W, Song J, Kim J, Lee M, et al. Expression of progesterone receptor in human keratinocytes. J Korean Med Sci 2000; 15: 647-654.
29. Urano R, Sakabe K, Seiki K, Ohkido M. Female sex hormone stimulates cultured human keratinocyte proliferation and its RNA- and protein-synthetic activities. J Dermatol Sci 1995; 9: 176-184.
30. Verdier-Sevrain S, Yaar M, Cantatore J, Traish A, Gilchrest BA. Estradiol induces proliferation of keratinocytes via a receptor mediated mechanism. FASEB J 2004; 18: 1252-1254.
31. Movérare S, Lindberg MK, Faergemann J, Gustafsson J, Ohlsson C. Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the hair follicle cycling as well as the thickness of epidermis in male mice. J Invest Dermatol 2002; 119: 1053-1058. (Pubitemid 35439124)
32. Gilliver SC, Ashcroft GS. Sex steroids and cutaneous wound healing: the contrasting influences of estrogens and androgens. Climacteric 2007; 10: 276-288.
33. Merlo S, Frasca G, Canonico PL, Sortino MA. Differential involvement of estrogen receptor alpha and estrogen receptor beta in the healing promoting effect of estrogen in human keratinocytes. J Endocrinol 2009; 200: 189-197.
34. Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci 2005; 38: 1-7. (Pubitemid 40410625)
35. Thornton MJ. Oestrogen functions in skin and skin appendages. Expert Opin Ther Targets 2005; 9: 617-629.
36. Jemec GB, Heidenheim M. The influence of sex hormones on UVB induced erythema in man. J Dermatol Sci 1995; 9: 221-224.
37. Widyarini S, Domanski D, Painter N, Reeve VE. Estrogen receptor signaling protects against immune suppression by UV radiation exposure. Proc Natl Acad Sci USA 2006; 103: 12837-12842. (Pubitemid 44298648)
38. Salem ML. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 2004; 3: 97-104.
39. Janele D, Lang T, Capellino S, Cutolo M, Da Silva JAP, Straub RH. Effects of testosterone, 17beta-estradiol, and downstream estrogens on cytokine secretion from human leukocytes in the presence and absence of cortisol. Ann NY Acad Sci 2006; 1069: 168-182. (Pubitemid 43989860)
40. Lengi AJ, Phillips RA, Karpuzoglu E, Ahmed SA. Estrogen selectively regulates chemokines in murine splenocytes. J Leukoc Biol 2007; 81: 1065-1074.
41. Kanda N, Watanabe S. 17Beta-estradiol inhibits MCP-1 production in human keratinocytes. J Invest Dermatol 2003; 120: 1058-1066. (Pubitemid 36702918)
42. Hirano S, Furutama D, Hanafusa T. Physiologically high concentrations of 17beta-estradiol enhance NF-kappaB activity in human T cells. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1465-1471.
43. Xing D, Feng W, Miller AP, Weathington NM, Chen Y, Novak L, et al. Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation. Am J Physiol Heart Circ Physiol 2007; 292: H2607-2612.
44. Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol 2005; 141: 601-606.
45. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci 1998; 1: 45-50.
46. O'Driscoll JB, August PJ. Exacerbation of psoriasis precipitated by an oestradiol-testosterone implant. Clin Exp Dermatol 1990; 15: 68-69.
47. Stevens HP, Ostlere LS, Black CM, Jacobs HS, Rustin MH. Cyclical psoriatic arthritis responding to anti-oestrogen therapy. Br J Dermatol 1993; 129: 458-460.
48. Boyd AS, King LE. Tamoxifen-induced remission of psoriasis. J Am Acad Dermatol 1999; 41: 887-889.
49. Jemec GB, Thorsteinsdóttir H, Wulf HC. The changing referral pattern in Danish dermatology - Rigshospitalet, Copenhagen, 1986-1995. Int J Dermatol 1997; 36: 453-456.
50. Zhang X, Wang H, Te-Shao H, Yang S, Chen S. The genetic epidemiology of psoriasis vulgaris in Chinese Han. Int J Dermatol 2002; 41: 663-669. (Pubitemid 35252042)
51. Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996; 135: 533-537.
52. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. New York (NY): Mosby; 2003.
53. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-456. (Pubitemid 15016489)
54. Smith AE, Kassab JY, Rowland Payne CM, Beer WE. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology 1993; 186: 181-186.
55. Swanbeck G, Inerot A, Martinsson T, Wahlström J, Enerbäck C, Enlund F, et al. Age at onset and different types of psoriasis. Br J Dermatol 1995; 133: 768-773.
56. Melski JW, Stern RS. The separation of susceptibility to psoriasis from age at onset. J Invest Dermatol 1981; 77: 474-477.
57. Lomholt G. Psoriasis - prevalence, spontaneous course, and genetics. Copenhagen: GEC Gad; 1963.
58. Boccardi D, Menni S, La Vecchia C, Nobile M, Decarli A, Volpi G, et al. Overweight and childhood psoriasis. Br J Dermatol 2009; 161: 484-486.